5:22 PM
 | 
Apr 08, 2014
 |  BC Extra  |  Financial News

AdvanDx secures $12 million in B-1 round

Molecular diagnostics company AdvanDx Inc. (Woburn, Mass.) raised $9 million in a $12 million series B-1 round led by new investor Merck Global Health Innovation Fund. Existing investors...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >